Search research articles
Contact Us
Filters
Showing results (311-320 of 335) with videos related to
Page
of 34
Sort By:
Blood
|
February 19, 2025
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT
Carmelo Gurnari, Marie Robin, Lionel Adès, et al.
The New England Journal of Medicine
|
December 12, 2023
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Pieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
Eclinicalmedicine
|
January 22, 2026
HCT Frailty Scale (HCT-FS) for assessing frailty in adult candidates for allogeneic haematopoietic cell transplantation: an international prospective, observational cohort study
María Queralt Salas, Tommy Alfaro Moya, Ivan Pasic, et al.
Bone Marrow Transplantation
|
March 15, 2023
Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era
Alberto Mussetti, Leyre Bento, Mariana Bastos-Oreiro, et al.
Nature Communications
|
September 20, 2023
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Cirino Botta, Cristina Perez, Marta Larrayoz, et al.
Future Oncology (London, England)
|
September 17, 2024
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
Pieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
Therapeutic Advances in Medical Oncology
|
September 9, 2021
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
Gehan Soosaipillai, Anjui Wu, Gino M Dettorre, et al.
Experimental Hematology & Oncology
|
September 1, 2020
Risk factors and outcome of COVID-19 in patients with hematological malignancies
José Luis Piñana, Rodrigo Martino, Irene García-García, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 20, 2014
Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma
Baldeep Wirk, Timothy S Fenske, Mehdi Hamadani, et al.
American Journal of Hematology
|
August 19, 2024
Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT)
Laurent Garderet, Luuk Gras, Linda Koster, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 335) with videos related to
Sort By:
Page
of 34
Blood
|
February 19, 2025
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT
Carmelo Gurnari, Marie Robin, Lionel Adès, et al.
The New England Journal of Medicine
|
December 12, 2023
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Pieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
Eclinicalmedicine
|
January 22, 2026
HCT Frailty Scale (HCT-FS) for assessing frailty in adult candidates for allogeneic haematopoietic cell transplantation: an international prospective, observational cohort study
María Queralt Salas, Tommy Alfaro Moya, Ivan Pasic, et al.
Bone Marrow Transplantation
|
March 15, 2023
Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era
Alberto Mussetti, Leyre Bento, Mariana Bastos-Oreiro, et al.
Nature Communications
|
September 20, 2023
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Cirino Botta, Cristina Perez, Marta Larrayoz, et al.
Future Oncology (London, England)
|
September 17, 2024
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
Pieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
Therapeutic Advances in Medical Oncology
|
September 9, 2021
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
Gehan Soosaipillai, Anjui Wu, Gino M Dettorre, et al.
Experimental Hematology & Oncology
|
September 1, 2020
Risk factors and outcome of COVID-19 in patients with hematological malignancies
José Luis Piñana, Rodrigo Martino, Irene García-García, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 20, 2014
Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma
Baldeep Wirk, Timothy S Fenske, Mehdi Hamadani, et al.
American Journal of Hematology
|
August 19, 2024
Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT)
Laurent Garderet, Luuk Gras, Linda Koster, et al.
Page
of 34